Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
Clinical trial NCT02963090 · TERMINATED
Trial details
- NCT number
- NCT02963090
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-20
- Primary completion
- 2019-06-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.